Filter Results:
(223)
Show Results For
- All HBS Web (223)
- Faculty Publications (148)
Show Results For
- All HBS Web (223)
- Faculty Publications (148)
- 2009
- Working Paper
Applying the Care Delivery Value Chain: HIV/AIDS Care in Resource Poor Settings
By: Joseph Rhatigan, Sachin H Jain, Joia S. Mukherjee and Michael E. Porter
The care delivery value chain is a framework that can help conceptualize the organization and structure of care delivery for medical conditions. We apply this framework to HIV/AIDS care in resource-limited settings. Several conclusions arise than can help inform... View Details
Keywords: Customer Value and Value Chain; Framework; Health Care and Treatment; Health Disorders; Service Delivery
Rhatigan, Joseph, Sachin H Jain, Joia S. Mukherjee, and Michael E. Porter. "Applying the Care Delivery Value Chain: HIV/AIDS Care in Resource Poor Settings." Harvard Business School Working Paper, No. 09-093, February 2009.
- 01 Apr 2020
- News
Happy Because He’s Blind
Chad Foster (PLDA 21, 2016) was just three years old when his vision began to fail; diagnosed with retinitis pigmentosa, he was legally blind by his early 20s. “It was really a difficult period for me trying to figure out what I was going to do and what my life was... View Details
- 24 Apr 2014
- News
Personal crises inform a life’s work
One of the youngest women to attend HBS, Amy Schiffman Langer (MBA 1977) was building a successful investment banking career when a cancer diagnosis at age 29 spurred her to volunteer at the National Alliance of Breast Cancer Organizations. She eventually became the... View Details
- 08 Feb 2021
- News
How Managers Can Support Employees with Chronic Illnesses
- June 2010 (Revised March 2014)
- Teaching Note
Deworming Kenya: Translating Research into Action (A) and (B)
By: Nava Ashraf, Neil Buddy Shah, Rachel Gordon and Elena Moroz
Teaching Note for 910001. View Details
- June 2024
- Supplement
Legacy Partners (B)
By: Richard S. Ruback and Royce Yudkoff
Pre-abstract: Instructors should consider the timing of making videos available to students, as they may reveal key case details.
Abstract: Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months... View Details
Keywords: Acquisition; Small Business; Cost vs Benefits; Decisions; Business Education; Corporate Entrepreneurship; Leadership Style; Leading Change; Business or Company Management; Problems and Challenges; Health Care and Treatment; Health Disorders; Medical Specialties; Nutrition; Supply Chain Management; Growth Management; Health Industry; Health Industry; United States; California
Ruback, Richard S., and Royce Yudkoff. "Legacy Partners (B)." Harvard Business School Multimedia/Video Supplement 224-726, June 2024.
- 01 Dec 2013
- News
Your Own Medicine
drug he has ever taken that directly targets his DMD, a rare degenerative disorder in boys that weakens the body's muscles, usually putting sufferers in wheelchairs in adolescence and shutting down their heart and lungs in their 20s. For... View Details
- January 2003 (Revised May 2003)
- Case
Heineken NV: Workplace HIV/AIDS Programs in Africa (A)
This case is the first in a three-part series that explores the multifaceted organizational and strategic choices that companies now face as a result of the global AIDS epidemic. Heineken is considering becoming one of the first companies to offer AIDS drugs... View Details
Keywords: Health Disorders; Corporate Social Responsibility and Impact; Employees; Food and Beverage Industry; Africa
Barrett, Diana, and Daniella Ballou. "Heineken NV: Workplace HIV/AIDS Programs in Africa (A)." Harvard Business School Case 303-063, January 2003. (Revised May 2003.)
- Web
VBHCD Initiative - Institute For Strategy And Competitiveness
kidney disease Diabetes Congestive heart failure Care transition patients to reduce frequency of readmission Primary and psychiatric care for patients with intellectual and behavioral disabilities Behavioral health for post-traumatic... View Details
- 2017
- Article
Blunted Ambiguity Aversion During Cost-Benefit Decisions in Antisocial Individuals
By: Joshua W. Buckholtz, Uma R. Karmarkar, Shengxuan Ye, Grace M. Brennan and Arielle Baskin-Sommers
Antisocial behavior is often assumed to reflect aberrant risk processing. However, many of the most significant forms of antisocial behavior, including crime, reflect the outcomes of decisions made under conditions of ambiguity rather than risk. While risk and... View Details
Keywords: Ambiguity; Neuroscience; Neuroeconomics; Choice; Psychology; Decision Choice And Uncertainty; Behavior; Decision Choices and Conditions; Cost vs Benefits; Health Disorders
Buckholtz, Joshua W., Uma R. Karmarkar, Shengxuan Ye, Grace M. Brennan, and Arielle Baskin-Sommers. "Blunted Ambiguity Aversion During Cost-Benefit Decisions in Antisocial Individuals." Art. 2030. Scientific Reports 7 (2017).
- 01 Jun 2017
- News
Turning Point: Addiction’s Impact
image by Jeffrey Decoster image by Jeffrey Decoster I was blindsided when my daughter told me, “I’m a heroin addict.” It was November 16, 2009, at a meeting with her drug counselor at Boston College. After I uttered a profanity and slammed my keys on the table, Amy... View Details
Keywords: Melissa Weiksnar (MBA 1982)
- 01 Jun 2002
- News
Up to the Challenge: Martin Gonzalez - Quiet Courage
Photography by Robert Schoen If I take one overall impression away from HBS, it's that everyone here has a powerful story to tell,” says Martin Gonzalez, a lanky Chilean whose own life story took a dramatic turn during his first year at Soldiers Field. A former... View Details
- 21 Mar 2012
- News
O'Donnells donate $30 million to Harvard
- January 2003 (Revised May 2003)
- Case
AngloGold - Corporate Responsibility for HIV/AIDS (A)
AngloGold, a South African gold-mining corporation, faces a decision to provide its workforce, 30% of which is infected with HIV, with antiretroviral treatment. View Details
Keywords: Health Disorders; Corporate Social Responsibility and Impact; Employees; Mining Industry; South Africa
Barrett, Diana, and Amanda Key. "AngloGold - Corporate Responsibility for HIV/AIDS (A)." Harvard Business School Case 303-101, January 2003. (Revised May 2003.)
- 2007
- Chapter
Fighting AIDS, Fighting Poverty: Customer Centric Marketing in the Generic Antiretroviral Business
By: Rohit Deshpandé and Zoe Chance
Keywords: Health Disorders; Poverty; Product Marketing; Customers; Pharmaceutical Industry; Biotechnology Industry
Deshpandé, Rohit, and Zoe Chance. "Fighting AIDS, Fighting Poverty: Customer Centric Marketing in the Generic Antiretroviral Business." In Business Solutions for the Global Poor: Creating Social and Economic Value, edited by V. Kasturi Rangan, John A. Quelch, Gustavo Herrero, and Brooke Barton. John Wiley & Sons, 2007.
- 2003
- Chapter
La tragédie de la thalidomide: affaires judiciaries et résponses législatives, 1959-1971
By: Arthur A. Daemmrich
- September 2006 (Revised July 2012)
- Case
PSI India—Will Balbir Pasha Help Fight AIDS? (A)
By: Elie Ofek and Peter Wickersham
In 2002, Population Services International (PSI) was committed to curbing the growing HIV/AIDS epidemic in India. Sanjay Chaganti, program director of HIV/AIDS at PSI India, has to decide on the best communication strategy to achieve this goal. Up to this date most... View Details
Keywords: Advertising Campaigns; Communication Strategy; Health Disorders; Marketing Communications; Social Marketing; Social Enterprise; India
Ofek, Elie, and Peter Wickersham. "PSI India—Will Balbir Pasha Help Fight AIDS? (A)." Harvard Business School Case 507-032, September 2006. (Revised July 2012.)
- 01 Jun 2013
- News
Lab Work
After 16 years at the Australian technology-transfer organization UniQuest, managing director David Henderson (MBA 1989) is moving on to new challenges. Looking back on the experience of shepherding technologies from the university to the marketplace—the... View Details
- April 1989 (Revised January 1994)
- Case
Novo Industri
By: Michael E. Porter and Michael J. Enright
Describes the structure of the insulin industry, a treatment for diabetes and Novo's strategy and competitive position in early 1982. The industry is undergoing significant change and Novo must decide how to defend and build its international position. Designed as an... View Details
Keywords: Change; Global Strategy; Industry Structures; Alliances; Competitive Strategy; Health Disorders; Pharmaceutical Industry
Porter, Michael E., and Michael J. Enright. "Novo Industri." Harvard Business School Case 389-148, April 1989. (Revised January 1994.)
- 2009
- Working Paper
Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location
By: Arthur Daemmrich
A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based organizations have assumed greater... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Health Testing and Trials; Power and Influence; Competitive Strategy; Pharmaceutical Industry; European Union; Germany; United States
Daemmrich, Arthur. "Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location." Harvard Business School Working Paper, No. 09-118, April 2009.